Borresen-Dale AL - Search Results

1

Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism.

Kristensen VN, Borresen-Dale AL. Kristensen VN, et al. Mutat Res. 2000 Apr;462(2-3):323-33. doi: 10.1016/s1383-5742(00)00018-1. Mutat Res. 2000. PMID: 10767642 Review.

2

Screening for ESR mutations in breast and ovarian cancer patients.

Anderson TI, Wooster R, Laake K, Collins N, Warren W, Skrede M, Elles R, Tveit KM, Johnston SR, Dowsett M, Olsen AO, Møller P, Stratton MR, Børresen-Dale AL. Anderson TI, et al. Hum Mutat. 1997;9(6):531-6. doi: 10.1002/(SICI)1098-1004(1997)9:6<531::AID-HUMU6>3.0.CO;2-4. Hum Mutat. 1997. PMID: 9195227

3

Improved electrophoretic separation of polymorphic short tandem repeats in agarose gels using bis-benzimide.

Kristensen VN, Børresen-Dale AL. Kristensen VN, et al. Biotechniques. 1997 Oct;23(4):634-6. doi: 10.2144/97234bm18. Biotechniques. 1997. PMID: 9343680 Free article. No abstract available.

4

Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.

Andersen TI, Eiken HG, Couch F, Kaada G, Skrede M, Johnsen H, Aloysius TA, Tveit KM, Tranebjaerg L, Dørum A, Møller P, Weber BL, Børresen-Dale AL. Andersen TI, et al. Hum Mutat. 1998;11(2):166-74. doi: 10.1002/(SICI)1098-1004(1998)11:2<166::AID-HUMU10>3.0.CO;2-X. Hum Mutat. 1998. PMID: 9482581

5

A rare CYP19 (aromatase) variant may increase the risk of breast cancer.

Kristensen VN, Andersen TI, Lindblom A, Erikstein B, Magnus P, Børresen-Dale AL. Kristensen VN, et al. Pharmacogenetics. 1998 Feb;8(1):43-8. doi: 10.1097/00008571-199802000-00006. Pharmacogenetics. 1998. PMID: 9511180

6

High-throughput screening for known mutations by automated analysis of single sequencing reactions.

Kristensen T, Kristensen VN, Børresen-Dale AL. Kristensen T, et al. Biotechniques. 1998 May;24(5):832-5. doi: 10.2144/98245dt04. Biotechniques. 1998. PMID: 9591134 Free article.

7

The APC gene I1307K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer.

Lothe RA, Hektoen M, Johnsen H, Meling GI, Andersen TI, Rognum TO, Lindblom A, Børresen-Dale AL. Lothe RA, et al. Cancer Res. 1998 Jul 15;58(14):2923-4. Cancer Res. 1998. PMID: 9679946

8

Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction.

Bjørheim J, Lystad S, Lindblom A, Kressner U, Westring S, Wahlberg S, Lindmark G, Gaudernack G, Ekstrøm P, Røe J, Thilly WG, Børresen-Dale AL. Bjørheim J, et al. Mutat Res. 1998 Jul 17;403(1-2):103-12. doi: 10.1016/s0027-5107(98)00057-8. Mutat Res. 1998. PMID: 9726011

9

CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1.

Nedelcheva Kristensen V, Haraldsen EK, Anderson KB, Lønning PE, Erikstein B, Kåresen R, Gabrielsen OS, Børresen-Dale AL. Nedelcheva Kristensen V, et al. Cancer Res. 1999 Jun 15;59(12):2825-8. Cancer Res. 1999. PMID: 10383140

10

Truncating somatic mutation in exon 15 of the APC gene is a rare event in human breast carcinomas. Mutations in brief no. 179. Online.

Sørlie T, Bukholm I, Børresen-Dale AL. Sørlie T, et al. Hum Mutat. 1998;12(3):215. Hum Mutat. 1998. PMID: 10660330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

507 results

Search Page